Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update

Author(s): Asim Azhar*, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, Jae-Jung Dong, Mohammad Amjad Kamal, Mohammad Owais

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 10 , 2021


Article ID: e170821191027
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

The unrelenting protraction of Coronavirus Disease 2019 (COVID-19), inflicted by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is tending to craft havoc all over the world for the past few months. Considering the looming repercussions due to this deadly virus worldwide, there is an impending necessity to comprehend this newfangled contagion. To develop an effective eradication measure and preventive strategy, knowledge about the virus structure, life cycle, and metabolism is imperative. Better insight into the virus life cycle helps us to identify and design drugs that can hit crucial targets of this dreadful virus. The close genetic similarity between SARS-CoV-2 and SARS-CoV, which triggered an outbreak in the year 2003, could be of great strategic importance in designing effective drug formulations. This will also help in the development of leveraging immunological measures to develop an effective vaccine against SARS-CoV-2. This eventually will help us to progress our strategies related to the virus. Not on the positive side, there is some misinformation going all around the world despite the strict regulations from the WHO and other government agencies to inform the citizens to abstain from the rumour-mongering regarding COVID-19. Further, evidence needs to be gathered on vaccine strategies to cure the patients suffering from COVID-19. This information will also help us in designing both drug inhibitors as well as prophylactic measures against SARS-CoV-2.

Keywords: COVID-19, Corona virus disease, ACE 2, angiotensin-converting enzyme 2, severe acute respiratory syndrome, middle east respiratory syndrome, SARS-CoV, coronaviruses.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 2
ISSUE: 10
Year: 2021
Published on: 02 February, 2021
Article ID: e170821191027
Pages: 16
DOI: 10.2174/2666796702666210202125638

Article Metrics

PDF: 13